» Articles » PMID: 39744123

Pathologic Function and Therapeutic Potential of Extracellular Vesicle MiRNA in Sepsis

Overview
Journal Front Pharmacol
Date 2025 Jan 2
PMID 39744123
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis is a systemic inflammatory response initiated by an infection, which can lead to multi-organ dysfunction. The pathophysiology of sepsis is complex, and treatment options are limited. Traditional antibiotic therapies have shown limitations, such as promoting the emergence of antibiotic-resistant bacteria and disrupting the natural microbiota. Consequently, there is a pressing need to explore diverse therapeutic approaches for sepsis management. Extracellular vesicles, which play a crucial role in cell-to-cell communication, are released by various cell types throughout the body and possess a membrane structure composed of a lipid bilayer. MicroRNAs may be encapsulated within these structures and can be selectively delivered to target recipient cells through the activation of cell surface receptors or via endocytosis and fusion, thereby modulating the biological functions of target cells. The article examines the pathological alterations that happen as sepsis progresses and the biological control of extracellular vesicles and microRNAs in sepsis. This review focuses on the role of extracellular vesicles and their microRNAs on controlling the inflammatory response, macrophage polarization, programmed cell death, endothelial dysfunction, and microcirculatory changes in sepsis. Furthermore, the obstacles encountered by this novel therapy are also examined.

Citing Articles

Circulating extracellular vesicles as potential biomarkers and mediators of acute respiratory distress syndrome in sepsis.

do Nascimento M, Ferreira L, Vieira Junior J, Deheinzelin D, Aparecida Santos Nussbaum A, Toshihiro Sakamoto L Sci Rep. 2025; 15(1):5512.

PMID: 39953195 PMC: 11829037. DOI: 10.1038/s41598-025-89783-7.

References
1.
Azevedo L, Janiszewski M, Pontieri V, Pedro M, Bassi E, Tucci P . Platelet-derived exosomes from septic shock patients induce myocardial dysfunction. Crit Care. 2007; 11(6):R120. PMC: 2246209. DOI: 10.1186/cc6176. View

2.
Appiah M, Park E, Darkwah S, Kawamoto E, Akama Y, Gaowa A . Intestinal Epithelium-Derived Luminally Released Extracellular Vesicles in Sepsis Exhibit the Ability to Suppress TNF-a and IL-17A Expression in Mucosal Inflammation. Int J Mol Sci. 2020; 21(22). PMC: 7696152. DOI: 10.3390/ijms21228445. View

3.
Chen K, Li Y, Xu L, Qian Y, Liu N, Zhou C . Comprehensive insight into endothelial progenitor cell-derived extracellular vesicles as a promising candidate for disease treatment. Stem Cell Res Ther. 2022; 13(1):238. PMC: 9172199. DOI: 10.1186/s13287-022-02921-0. View

4.
Niu R, Pan P, Li C, Luo B, Ma H, Hao H . Bone mesenchymal stromal cell-derived small extracellular vesicles inhibit inflammation and ameliorate sepsis via delivery of microRNA-21a-5p. Cytotherapy. 2023; 25(6):625-639. DOI: 10.1016/j.jcyt.2023.02.002. View

5.
El Andaloussi S, Mager I, Breakefield X, Wood M . Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013; 12(5):347-57. DOI: 10.1038/nrd3978. View